The FDA seeks OMB clearance for information collection procedures related to premarket approval of medical devices under the Paperwork Reduction Act.
Texas Stock Exchange amends continued listing standards for ETF shares related to beneficial holder requirements under Rule 17.104(b)(2)(B).
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
NYSE American amends its connectivity fee schedule for market data and trading access; the rule change is effective immediately.
NYSE Arca proposes amendments to its connectivity fee schedule, effective immediately upon SEC filing.
NYSE National amends its connectivity fee schedule under self-regulatory authority, with the rule change immediately effective upon filing.
FINRA proposes Rule 4321 on fail-to-deliver allocations and amends Rule 4560 on short-interest reporting, with the SEC extending its review period for this regulatory change affecting broker-dealers.
NYSE Texas, Inc. amends its connectivity fee schedule to adjust charges for market data and trading access services.
NYSE American modifies its options fee schedule for manual transactions, with changes effective immediately.
FDA determines that vasopressin 0.9% injection was not withdrawn for safety or effectiveness reasons, allowing approval of generic abbreviated new drug applications if other regulatory requirements are met.
I need more information to create a summary. Please provide a description of what this document is about, including relevant facts such as deadlines, dollar amounts, affected industries, or scope for small businesses.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
